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Cognitive Mechanisms of
Nicotine on Visual Attention
ever, the neural basis of nicotine’s attention-enhancing
effects in general and on the RVIP task in particular has
not been directly addressed and was the aim of the
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present study.2 Department of Pharmacology
Previous research suggests that nicotine exerts its3 Department of Cellular Biology
cognitive effects by modulating activity in one or more4 Biophysics Research Institute
regions associated with mechanisms of sustained atten-Medical College of Wisconsin
tion (see Coull, 1998; Parasuraman et al., 1998; SarterMilwaukee, Wisconsin 53226
et al., 2001, for reviews). Using positron emission tomog-
raphy (PET), Coull et al. (1996) demonstrated that RVIP
task performance activated frontal, parietal, and occipi-Summary
tal cortex, regions implicated in sustained attention by
other brain imaging and lesion studies (Rueckert andUnderstanding nicotine’s neurobiological and cognitive
Grafman, 1996, 1998; Cabeza and Nyberg, 2000). Thala-mechanisms may help explain both its addictive proper-
mic, midbrain, and brain stem reticular activating systemties and potential therapeutic applications. As such,
structures control arousal (Kinomura et al., 1996; Pausfunctional MRI was used to determine the neural sub-
et al., 1997; Coull et al., 1998; Marrocco and Davidson,strates of nicotine’s effects on a sustained attention
1998), an important modulator of sustained attention(rapid visual information-processing) task. Perfor-
(Edwards et al., 1985; Coull, 1998; Knott et al., 1999).mance was associated with activation in a fronto-pari-
Of crucial importance in sustained attention is theetal-thalamic network in both smokers and nonsmok-
ascending cholinergic (ACh) system originating in theers. Along with subtle behavioral deficits, mildly
basal forebrain and projecting to most of the cortex
abstinent smokers showed less task-induced brain
(Muir et al., 1995; Everitt and Robbins, 1997), with the
activation in the parietal cortex and caudate than did
ascending noradrenergic (NA) projection from the locus
nonsmokers. Transdermal nicotine replacement im-
coeruleus postulated to mediate the effects of arousal
proved task performance in smokers and increased
on sustained attention (Aston-Jones et al., 1994; Coull,
task-induced brain activation in the parietal cortex, 1998; Sarter et al., 2001). The importance of ACh and
thalamus, and caudate, while nicotine induced a gen- NA are supported by findings that nicotine reverses im-
eralized increase in occipital cortex activity. These pairments on the RVIP task induced by the muscarinic
data suggest that nicotine improves attention in smok- antagonist scopolamine (Wesnes and Revell, 1984) and
ers by enhancing activation in areas traditionally asso- in individuals with dementia of the Alzheimer’s type (Sa-
ciated with visual attention, arousal, and motor acti- hakian et al., 1989, Jones et al., 1992), a disease charac-
vation. terized by reduced cholinergic function (Whitehouse et
al., 1982). The NA agonist clonidine, which acts presyn-
Introduction aptically to reduce NA transmission, induces opposite
effects and impairs RVIP task performance (Coull et al.,
Nicotine is known to improve performance on a range 1995). Furthermore, scopolamine and clonidine prevent
the changes in cortical arousal associated with sus-of cognitive tasks, notably, attention and, to a lesser
tained attention and that follow acute nicotine adminis-extent, working memory in humans and animals (Sher-
tration (Knott et al., 1999). Taken together, these findingswood, 1993; Stolerman et al., 1995; Rezvani and Levin
suggest that nicotine may enhance sustained attention2001), which could contribute to smoking maintenance
by increasing cortical arousal via ascending ACh andby improving concentration (Russell et al., 1974). One
NA projections.of the drug’s most robust and consistent cognitive ef-
Previous brain imaging studies suggest that intrave-fects is improved performance on the rapid visual infor-
nous nicotine selectively increases regional cerebralmation-processing (RVIP) task (Wesnes and Warburton,
blood flow (rCBF) in parieto-occipital regions in smokers1983; Sherwood, 1993); a task that requires sustained
and nonsmokers performing a maze test (Ghatan et al.,attention (vigilance) and working memory for its execu-
1998) and activates cortical (including portions of thetion. Furthermore, studies comparing RVIP performance
frontal, parietal, occipital, insula, temporal, and cingu-in smokers and nonsmokers suggest that nicotine
late cortex) and subcortical limbic regions (nucleus ac-enhances performance above some normal baseline
cumbens, amygdala, thalamus) in nonabstinent smok-(Wesnes and Warburton, 1984; Warburton and Arnall,
ers (Stein et al., 1998).1994; Foulds et al., 1996), rather than by alleviating a
Based on these data, it was hypothesized that thewithdrawal-induced deficit in abstinent smokers. How-
RVIP task would activate parieto-occipital areas, and
this activation would be increased by nicotine to medi-
5 Correspondence: estein@intra.nida.nih.gov ate an expected drug-induced performance enhance-
6 Present address: Section of Neuroscience and Emotion, Department
ment. To test this hypothesis, 15 smokers with and with-of Psychological Medicine, Institute of Psychiatry, London SE5 8AF.
out a 21 mg transdermal nicotine patch performed the7 Present address: Neuroimaging Research Branch, National Insti-
RVIP task while undergoing fMRI scanning. Placebo andtute on Drug Abuse-Intramural Research Program, 5500 Nathan
Shock Drive, Baltimore, Maryland 21224. nicotine patch application was counterbalanced across
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Table 1. Task Performance in Nonsmokers and in Smokers with Placebo and Nicotine
Smokers
PN  Placebo PN  Nicotine NP  Placebo NP  Nicotine
Performance Measure (Scan 1) (Scan 2) (Scan 2) (Scan 1) Nonsmokers
Hits (max 96)
RVIP task 46.5  5.9 62.1 7.0 56.7 3.2 53.3  3.5 62.3  5.0
Control task 93.2  0.4 91.4  2.7 92.4  0.8 92.6  1.3 94.1  0.8
RT (ms)
RVIP task 556.9  30.4 529.2  27.4 639.6  31.7 655.7  40.5 574.7  34.8
Control task 489.3  13.7 483.0  16.3 527.2  27.7 510.5  31.1 477.5  18.9
False alarms
RVIP task 3.9  1.1 5.9  2.3 10.4  6.6 4  1.7 3.1  0.5
Control task 0.2  0.2 0.5  0.4 0.1  0.1 0  0 1  0.7
Performance measures (Mean  SEM) on RVIP and control tasks for smokers separated based on treatment order (PN and NP, respectively,
given placebo or nicotine during the first scanning session) and nonsmokers (matched to the PN  placebo scan, n  7).
two scan sessions. In addition, the present study com- Mood Changes
As time-dependent changes in mood resulting from apared “baseline” (nicotine-free) performance and task-
induced brain activation in smokers to that of nonsmok- transdermal nicotine patch have been reported (Warbur-
ton and Mancuso, 1998), smokers completed a briefers matched for age and education.
mood scale (Parrott et al., 1996) on three occasions:
prior to patch application, 2 hr after patch, and after theResults
scan (about 3.25 hr after patch). Nonsmokers completed
the mood scale pre- and postscan. In smokers, moodRVIP Task Performance
changes occurred from pre- to postscan only, sug-
Subjects performed the RVIP task and a sensorimotor
gesting that the nicotine or placebo patch alone did not
control task consecutively in a pseudorandom alternat-
impact subjective ratings of mood but did influence the
ing block design. Complete behavioral and imaging de-
changes in mood induced by performing a demanding
tails are given in Experimental Procedures. The mean
attention task in the scanner. Ratings of energy varied
values for performance indices (number of targets iden-
over time [F(2,28) 4.4, p 0.05] with a significant drop intified [“hits”], number of false alarms and mean reaction
energy levels pre- to postscan in smokers with placebo
time [RT] to hits) per drug condition and per task in
patch [t(28)  3.1, p  0.01] but not in smokers withsmokers and nonsmokers are given in Table 1.
nicotine patch [t(28)  0.86, p  0.4]. Similarly, there was
a trend toward a drop in ratings of focus over time
Performance Differences in Smokers [F(2,28)  3.22, p  0.055], again with a drop in focus pre-
The ANOVA on number of hits revealed significant task
drug  treatment order interactions [F(1, 13)  15.76, p 
0.01]. Post-hoc t tests indicated that nicotine increased
the number of hits on the RVIP task in smokers that
received placebo on scan 1 and nicotine on scan 2 (PN
group [t(13)  6.09, p  0.0001]) (Figure 1). There was no
difference in RVIP task performance in smokers who
received nicotine prior to scan 1 and placebo on scan
2 (NP [t(13)  1.25, p  0.1]).
There was a significant between-subjects effect on
mean RT to hits in the RVIP task (task treatment order
[F(1, 13)  6.35, p  0.05]). Subjects in the PN group were
faster to respond overall than subjects in the NP group
[t(13)  8.68, p  9  107]. Nicotine had no effect on
mean RT to hits and did not interact with the difference
in RT between groups. Neither drug nor treatment order
had an effect on the number of false alarms in either
task.
Figure 1. Number of Hits in Smokers with Placebo and NicotineDifference between Smokers and Nonsmokers
PatchPerformance data from nonsmokers’ and placebo-
Number of hits out of a maximum of 96 (mean  SEM) in smokerspatched smokers’ first scan sessions (nonsmokers per-
during performance of the control and RVIP task with placebo andformed only one scan) revealed no significant differ-
nicotine patch, based upon treatment order, where plac-nic are the
ences on either task (Table 1), although there was a smokers who received placebo on their first scan (n  8), and nic-
trend toward the former group identifying more hits than plac are the smokers who received nicotine patch on their first scan
(n  7). *p  0.05.the latter [F(1,14)  3.7, p  0.076].
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to postscan in the placebo [t(28)  2.24, p  0.05] but tine [F(1,13)  16.59, p  0.01 left; and F(1,13)  6.96, p 
0.05 right]. There was no significant task drug interac-not in the nicotine condition [t(28) 1.23, p 0.1]. Ratings
of both contentment and happiness varied over time tions in the occipital cortex, suggesting that nicotine
had general enhancement effects on the BOLD signal[F(2, 28)  4.36, p  0.05; F(2, 28)  5.96, p  0.01, respec-
tively]; for happiness, there was a significant decrease (Figures 2C and 2D).
Nicotine also caused a general BOLD increase in bilat-in pre- to postscan ratings in smokers with placebo
patch [t(28)  2.65, p  0.01], although for contentment, eral thalamus (Figures 3A and 3B) [F(1,13) 5.13, p 0.05
right; F(1,13) 7.0, p 0.05 left]. A significant task drugthis occurred in smokers in the nicotine condition [t(28) 
2.62, p  0.05]. Smokers given placebo on scan 1 interaction in the left thalamus F(1,13)  6.39, p  0.05]
indicated a greater drug effect during performance ofshowed more of a decrease in mood pre- to postscan
than did nonsmokers. Energy decreased in smokers with the RVIP task [t(13)  5.79, p  104]. Finally, nicotine
increased BOLD signal in bilateral caudate in smokers.placebo patch but not in nonsmokers [time  smoking
status: F(1, 13)  5.64, p  0.05; decrease in smokers: While nicotine caused a general increase in activation
in the left caudate [drug: F(1,13)  7.64, p  0.05] (Figuret(13)  2.98, p 0.05]. Smokers’ postscan energy ratings
were lower than those in nonsmokers [t(13)  3.42, p  3C), a significant task drug treatment order interac-
tion [F(1,13)  9.05, p  0.01] arose in the right caudate0.01]. There were also time  smoking status interac-
tions for ratings of contentment [F(1, 13)  10.4, p  0.01], nucleus from nicotine increasing activation in the RVIP
task in smokers who received nicotine during their sec-satisfaction [F(1, 13) 5.12, p 0.05], Focus [F(1, 13)  6.71,
p  0.05], and happiness [F(1, 13)  9.1, p  0.01]. For all ond scan session [t(13)  6.03, p  104].
In brain areas “deactivated” during performance ofof these moods, the interaction arose from mood rat-
ings in smokers with placebo falling pre- to post- the RVIP task, nicotine increased activation overall in
the posterior cingulate [drug: F(1,13)  4.63, p  0.05].scan, whereas ratings in nonsmokers increased pre- to
postscan. Nicotine further decreased BOLD signal in the left insula
(Figure 3D), during RVIP task performance [task  drug
interaction: F(1,13)  5.68, p  0.05, drug effect in RVIPfMRI Activation
task: t(13)  3.31, p  0.01], and in two clusters in theFunctional regions of interest (ROIs) were generated
left pHG in smokers receiving nicotine on their secondusing data from a subtraction analysis (RVIP task 
scan [task  drug  treatment order; F(1,13)  6.9, p control task) by calculating two-tailed t tests against the
0.05; t(13)  3.1, p  0.01 for the pHG, F(1,13)  7.7, p null hypothesis of no difference on the mean per voxel
0.05; t(13)  5.7, p  1  104 for the anterior pHG].signal differences across subjects. RVIP task perfor-
Finally, a task  treatment order interaction was seenmance was associated with increased activation in sev-
in the pre-SMA [F(1,13)  5.14, p  0.05]. The PN grouperal (predominantly right) frontal regions and bilaterally
showed significantly less activation than smokers in thein parietal cortex, thalamus, caudate, anterior insula,
NP group, an effect only present during RVIP task perfor-middle occipital/fusiform gyrus, and the cerebellar cul-
mance [t(13) 6.14, p104]. This between-group differ-men. RVIP task performance decreased BOLD signal
ence in activation could be linked to the fact that thein several left (predominantly medial) frontal regions,
PN group was faster to respond to hits than the NPbilateral anterior and posterior cingulate, insula, and left
group on the RVIP task, regardless of drug conditionparahippocampal gyrus (pHG). Similar task-induced ac-
(see above).tivations were found in all experimental groups. The
differences in activation between drug conditions and
groups are detailed below. Differences between Smokers and Nonsmokers
Comparison of smokers given placebo on their first scan
to nonsmokers suggested differences in task-inducedActivation Differences in Smokers
activation. Smokers showed less task-induced activa-Repeated-measures ANOVAs were performed on the
tion in the parietal cortex and caudate (both bilateral)mean activation value in each brain cluster (Table 2) in
when compared to nonsmokers (Figure 4). These differ-smokers with placebo (P) and nicotine (N), with task
ences were indicated by significant task smoking sta-(RVIP/control), drug (nicotine/placebo), and treatment
tus interactions in the right and left parietal cortexorder (PN/NP) as factors. Nicotine significantly increased
[F(1,13)  6.08, p  0.05, F(1,13)  4.77, p  0.05, respec-BOLD signal in the parietal and occipital cortex, thala-
tively] and in the right and left caudate [F(1,13)  7.98, pmus, and caudate (all bilateral, see Figures 2 and 3).
0.05, F(1,13)  6.44, p  0.05, respectively]. Post-hoc tNicotine also further decreased BOLD signal in some
tests revealed that these differences were specific toregions that were deactivated during task performance,
activation during RVIP task performance.including the left insula (Figure 3D). These effects were
independent of treatment order. The effect of nicotine
on BOLD signal in the left and right parietal cortex (Fig- Discussion
ures 2A and 2B) was evident as a task drug interaction
[F(1,13)  6.95, p  0.05 for the left; F(1,13)  9.2, p  0.01 Overview
Performance of the RVIP task activated bilateral frontal,for the right parietal cortex]. Post-hoc t tests indicated
that nicotine significantly increased BOLD signal in the parietal, thalamic, occipital, and cerebellar regions pre-
viously associated with sustained attention and workingparietal cortex during performance of the RVIP task only
[t(13)  4.63, p  0.001 left side; t(13)  4.58, p  0.001 memory (Posner and Petersen, 1990; Pardo et al., 1991;
Rueckert and Grafman, 1996, 1998; Coull, 1998; Cabezaright side]. Analysis of BOLD signal changes in the left
and right occipital cortex revealed a main effect of nico- and Nyberg, 2000). Additional strong task-induced acti-
Neuron
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Table 2. Clusters Showing Significant Differences in Activation between RVIP and Control Task
Center-of-Mass
Brain Region Side (R/L, A/P, S/I) Brodmann Area RVIP Task Activation
Frontal lobe
Middle and inferior frontal gyri, precentral gyrus R 43, 19, 24 9, 46 
R 29, 3, 46 6 
B (L  R) 42, 4, 30 6, 9 
L 24, 30, 34 9 
Pre-SMA, medial and superior frontal gyrus, cingulate B 1, 16, 44 6, 8, 32 
Medial frontal gyrus, anterior cingulate B (L  R) 4, 50, 6 10, 32 
Inferior frontal and precentral gyrus R 46, 11, 9 44, 13 
Superior frontal gyrus L 12, 41, 42 8 
Parietal lobe
Parietal lobule (inferior, superior, precuneus) R 31, 53, 44 40, 7, 19  ↑ 
L 29, 57, 42 40, 7, 19  ↑ 
Limbic/thalamic
Anterior cingulate B (R  L) 2, 34, 4 24 
Posterior cingulate B (L  R) 2, 44, 28 31  ↑
L 8, 54, 20 31, 23 
R 6, 52, 14 30 
Middle cingulate B (R  L) 1, 26, 25 23 
L 3, 12, 38 24 
Thalamus (mediodorsal, ventrolateral, pulvinar nuclei) L 12, 18, 14  ↑
R 5, 18, 10  ↑
Caudate L 14, 4, 17  ↑ 
R 10, 4, 17  ↑ *PN 
Insula
Anterior insula, claustrum R 32, 17, 2 13, 47 
Mid-insula, precentral gyrus L 31, 20, 1 47, 13 
R 42, 13, 13 13, 6 
Mid-insula, claustrum L 36, 14, 10 13 
L 35, 1, 10 13  ↓
Temporal lobe
Parahippocampal gyrus L 22, 30, 8 35, 27 ↓ *NP
Anterior parahippocampal gyrus, amygdala L 20, 13, 11 28, 35 ↓ *NP
Occipital lobe
Middle occipital, fusiform gyrus L 40, 63, 4 37, 19, 18  ↑
Middle occipital, fusiform gyrus, middle temporal gyrus R 42, 58, 5 37  ↑
Cerebellum
Cerebellum (culmen) L 27, 57, 25 
Cerebellum (culmen) R 28, 54, 26 
 and  symbols indicate clusters where there is, respectively, increased or decreased BOLD signal in the RVIP task relative to baseline and
control task. R, right; L, left; B, bilateral. The symbols in the far right column denote clusters showing a significant nicotine effect in smokers
or a significant difference in activation between smokers and nonsmokers. ↑, increased activation in smokers  nicotine versus placebo; ↓,
decreased activation in smokers  nicotine versus placebo; *, order-dependent nicotine effect (PN, effect in PN order; NP, effect in NP order);
, less active in smokers  placebo versus nonsmokers.
vations of the anterior insula and caudate were ob- facilitates the focusing of attentional resources on task
demands.served, while decreased activation in left frontal, anterior
and posterior cingulate, insula, and left parahippocam-
pal regions were also seen. Nicotine Effects on Performance
Application of a 21 mg nicotine patch to smokers Nicotine improved RVIP task performance in smokers
improved RVIP task performance and increased task- as a function of the scan session in which drug was
induced BOLD activation in attention-related areas bilat- administered. Smokers in the placebo-nicotine (PN)
erally including the parietal and occipital cortex, thala- group showed a large difference in performance be-
mus, and caudate. The nicotine patch also prevented tween scans, whereas smokers in the nicotine-placebo
the decline in mood ratings that followed task perfor- (NP) group failed to show a difference. The performance
mance in smokers with placebo patch. Nicotine adminis- on both scans in the NP group was midway between
tration further deactivated some of the brain regions the first and second scan in the PN group, suggesting
that both nicotine and practice improved performance,deactivated by the RVIP task, suggesting that nicotine
Nicotine and Attention Mechanisms
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Figure 2. Effects of Nicotine in Parietal and Occipital Cortex
Activated clusters are shown on a representative rendered brain and reflect the activation difference between the RVIP and control tasks in
smokers after placebo and nicotine patch treatment (cuts made at 60 mm posterior and 43 mm superior to the anterior commissure). The
graphs show the percent change in activation (from baseline) during performance of each task in smokers with placebo and with nicotine.
As there was no effect of treatment order on brain activation, data are presented collapsed for treatment order. A, left parietal cortex; B, right
parietal cortex; C, left occipital cortex; D, right occipital cortex.
and when these two factors co-occurred (the PN group), may have contributed to its performance-enhancing ef-
fects. The regionally specific increases in brain activa-there was a large (33%) increase in the number of hits.
The presence of practice effects that interacted with tion following nicotine are consistent with previous re-
ports (Ghatan et al., 1998; Stein et al., 1998) and arguedrug effects was somewhat surprising. All subjects had
received one training session on the task prior to their both against global drug effects on the BOLD signal and
refute the claim that acute nicotine tolerance (tachyphy-scan, following the results of a prior pilot bench study
that suggested one training session was sufficient to laxis) prevents drug-induced increases in activation
(Ernst et al., 2001). The regional specificity of the nicotineavoid practice effects. The present practice effects may
have been due to the transition from practicing the task effect is consistent with the distribution of nicotinic ACh
receptors in the human brain, with the highest densityon the bench to performing it while lying down inside a
noisy scanner. Despite these practice effects, the be- located in the thalamus, caudate, and substantia nigra,
and moderate to low densities in the frontal, parietal,havioral data point to nicotine enhancing the number
of hits in the RVIP task in smokers, both when it was temporal and occipital cortex, hippocampus, and cere-
bellum (Paterson and Nordberg, 2000).administered on the first and second scan. The nicotine-
induced enhancement of activation in smokers, regard- The present findings suggest that nicotine facilitated
RVIP task performance by increasing activation in pos-less of treatment order, reinforces the notion that nico-
tine facilitated sustained attention. terior cortical and subcortical regions related to the vi-
sual attention/arousal aspects of the task, rather than
by activating frontal regions mediating the more workingNicotine Modulation of Task-Induced
Brain Activation memory/target detection functions. This interpretation
is consistent with reports that nicotine activates parieto-The nicotine-enhanced BOLD signal increase seen in bilat-
eral parietal and occipital cortex, thalamus, and caudate occipital regions (Ghatan et al., 1998; Stein et al., 1998;
Neuron
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Figure 3. Effects of Nicotine in Thalamus and Caudate
Activated (red) and deactivated (blue) clusters reflect the difference between the RVIP and control tasks in smokers (cuts made at 17 mm
superior and 1 mm posterior to the anterior commissure). The graphs show the change in activation (from baseline) during performance of
each task in smokers following placebo and nicotine patch administration. There was no effect of treatment order. A, right thalamus; B, left
thalamus; C, left caudate; D, left insula.
Ernst et al., 2001) and with observations that these re- (Kievit and Kuypers, 1975; Mesulam et al., 1983; Murphy
and Klein, 1998), or by presynaptically increasing gluta-gions are critical for sustained attention tasks with a
fast stimulus presentation rate, as used here (Coull et mate transmission in the parietal cortex (Marrocco and
Davidson, 1998). The idea that nicotine mediates itsal., 1996; Rueckert and Grafman, 1998).
Nicotine’s BOLD-enhancing effects in parietal cortex effects on attention via excitation of parietal cortex activ-
ity has been suggested previously (Marrocco and David-were specific to the RVIP but not control task perfor-
mance. Thus, this site may be specifically related to son, 1998; Murphy and Klein, 1998); however, the pres-
ent data constitute evidence that nicotine-inducednicotine’s attention-enhancing effects, which are only
apparent when more effortful processing is required enhancement of parietal cortex activation is associated
with improved attention.(Bushnell et al., 2000). The idea that the parietal cortex
mediates nicotine’s attention-enhancing effects is sup- Nicotine also increased activation in the thalamus and
caudate, consistent with drug action in a previous reportported by its known involvement in the orientation and
maintenance of attention (Murphy and Klein, 1998; (Stein et al., 1998) and suggesting that nicotine causes
general increases in arousal and motor activation. TheRueckert and Grafman, 1998) and the observation in
monkeys that infusion of nicotine into the posterior pari- intralaminar nuclei and pulvinar nucleus of the thalamus
are particularly important for the maintenance of an alertetal cortex reduces RTs and enhances the reorientation
of attention in a cueing task (Bushnell et al., 2000). state (Coull, 1998), and it is possible that nicotine en-
hanced activation in these regions to facilitate the main-Given the seemingly important role for parietal cortex
activation in RVIP task performance, it is likely that nico- tenance of alertness during RVIP task performance. Ac-
tivation of the thalamic pulvinar nucleus and caudatetine improved task performance in smokers by enhanc-
ing activation within this region, possibly by increasing have also been linked to selective attention (LaBerge
and Buchsbaum, 1990; Corbetta et al., 1991; Coull etactivity in ascending cholinergic and noradrenergic
pathways, which may converge in the parietal cortex al., 1996). Thus, increased activation of these regions
Nicotine and Attention Mechanisms
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Figure 4. Task-Induced Activation in Smokers Relative to Nonsmokers
Activated (red) clusters represent the activation difference from baseline between the RVIP and control tasks in smokers who received placebo
during their first scan session (n  8) and in nonsmokers (n  7) (cuts made at 40 mm and 11 mm superior to and 2 mm anterior to the
anterior commissure). Note the significantly attenuated response during RVIP task performance in smokers wearing placebo patch compared
to the response in nonsmokers. A, right parietal cortex; B, left parietal cortex; C, right caudate; D, left caudate.
may have facilitated the filtering out of nontarget digits task (Furey et al., 2000). The present findings are consis-
tent with Furey et al.’s (2000) hypothesis that cholinergicand enhanced processing of digits composing possible
target sequences. Although nicotine had no effect on enhancement increases activation (signal-to-noise ratio)
in stimulus-specific regions of sensory cortex and aug-the small vigilance decrement observed in this study
(data not shown), smokers with nicotine showed im- ments the selectivity of perceptual processing (see also
Sarter et al., 2001).proved RVIP task performance over the whole task (as
in Mancuso et al., 1999) and failed to show the decreases The present data also point to nicotine modulating
areas deactivated by task performance, including a fur-in subjective ratings of energy and focus that accompa-
nied task performance in smokers with placebo. ther deactivation of left insula and left pHG. While the
functional implications of this enhanced “deactivation”Nicotine may have further facilitated task performance
in smokers by generally enhancing activity in the occipi- are unclear, it could reflect the inhibition of somatosen-
sory or emotional processing, while the observed ante-tal cortex/fusiform gyrus, consistent with prior reports
(Ghatan et al., 1998). Nicotine increased BOLD signal in rior cingulate deactivation may reflect the focusing of
attention on a prepotent goal (Coull et al., 1996; Gusnardthese higher-order visual cortices during performance
of both the RVIP and control tasks, possibly resulting and Raichle, 2001). Previous studies point to nicotine
deactivating the anterior cingulate during performancein a “bottom-up” enhancement of visual attention in both
tasks. It must be noted, however, that the performance- of demanding cognitive tasks (Ghatan et al., 1998; Ernst
et al., 2001), an effect that was not replicated. The effectsenhancing effects of nicotine were only evident during
the RVIP task, possibly due to ceiling effects on control on task-induced deactivation may be due, in part, to
nicotine increasing baseline activity in these areas (pos-task performance. Enhanced cholinergic function has
recently been shown to selectively increase activation terior and anterior cingulate, insula; Stein et al., 1998),
resulting in a need to further “shut down” these circuitin a stimulus-specific region of visual cortex during the
processing (encoding) of face stimuli in a working memory components in order to focus resources on task de-
Neuron
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last cigarette 15 min preceding the study. All subjects were askedmands. Comparison of smokers with nicotine to smok-
to abstain from alcohol consumption for 8 hr prior to the study. Toers with placebo lends credence to this idea, since acti-
avoid caffeine withdrawal, caffeine-using subjects were instructedvation in posterior cingulate and left pHG was enhanced
to consume one half-cup of caffeine-containing beverage at least
during control task performance in smokers with nicotine 2 hr prior to the study. A urine sample was obtained immediately
but further deactivated during RVIP task performance. prior to the study, and absence of drug use was confirmed with an
ELISA assay (TRIAGE).
Activation Differences in Smokers
Task
and Nonsmokers The RVIP task was composed of 90 s blocks of continuous stimuli
Smokers with placebo (who were 2.30 hr nicotine free) presentation. The 90 s block length was chosen in order to provide
showed hypoactivity in the parietal cortex and caudate, a sufficiently attentionally demanding task. Each block consisted of
a stream of single digits presented in the center of a computerareas associated with RVIP task performance, when
screen at a rate of 100 digits/min. Subjects pressed a button usingcompared with nonsmokers. This finding suggests that
their right index finger when they saw a target sequence of threechronic nicotine use attenuates task-related brain ac-
different odd or three different even numbers appearing consecu-
tivity. tively (e.g., 7-1-3, 2-4-6). Response accuracy was encouraged, and
The functional implications of this regional hypoactiv- correct responses to targets were recorded for up to 1.2 s after the
target sequence. Each block contained 12 pseudorandomly oc-ity in smokers are unclear. While smokers did not show
curring targets, with four targets appearing every 30 s. Targets werea significant deficit in RVIP task performance, there was
always separated by at least two digits, and the same digit nevera trend toward such a deficit. In addition, smokers re-
appeared consecutively. Eight blocks of RVIP task were performed
ported a greater decrease in ratings of energy and focus consecutively with eight blocks of control task, during which sub-
following RVIP task performance than did nonsmokers, jects pressed for “0.” The 0 replaced one of the three target se-
suggesting that smokers found performing the RVIP task quence digits in the stimuli used for the RVIP task. The sequence
of the two tasks was presented in a pseudorandom order and weremore emotionally draining than did nonsmokers. Previ-
followed by a 30 s rest period, during which subjects fixated on aous studies have shown deficits in cognitive perfor-
cross in the center of the screen. Subjects received a visual warningmance and mood in nicotine-abstinent smokers com-
of which task they were performing immediately prior to the block
pared to nonsmokers, with cognitive deficits emerging presentation. A reminder of the target type in the current block was
after 2 hr and mood deficits occurring after 4 hr of with- also displayed at the bottom of the screen throughout the task.
Stimuli were back-projected onto a screen at the subject’s feet anddrawal (e.g., Parrott et al., 1996). The present findings
were viewed with the aid of prism glasses attached to the inside ofsuggest that fMRI may be a more sensitive tool than
the RF head coil.existing behavioral measures in assessing differences
Performance was assessed separately for each task by calculat-
between smokers and nonsmokers, brain changes as- ing the number of targets detected (hits), false alarms, and the mean
sociated with short-term drug withdrawal, and the ame- reaction time (RT) to target stimuli. The scores per task and per scan
session were separately averaged across smokers in the nicotine (N)lioration of these with nicotine administration.
and placebo (P) conditions and the matched nonsmokers. Since aTaken together, the present findings suggest that nic-
practice effect was seen when performing the RVIP task across theotine improves visual sustained attention in cigarette
two scans, the order of treatment (PN or NP) was entered into a
smokers by increasing activation in bilateral parietal and repeated-measures ANOVA as a between-subjects factor. Since
occipital cortex, thalamus, and caudate. Smokers show nonsmokers only performed the task once, smoker and nonsmoker
comparisons are based only on subjects’ first scan sessions.hypoactivity in parietal cortex and caudate, along with
mild deficits in RVIP task performance when compared
Procedureto nonsmokers. These data do not invite predictions
Subjects underwent one practice session on the RVIP task during
about the effects of nicotine in nonsmokers, although the week preceding their scan. Smokers also applied a nicotine
it is likely, based on the findings of Ghatan et al. (1998) patch for a minimum of 3 hr to check for any adverse reactions prior
and Foulds et al. (1996), that similar nicotine-induced to scanning. Smokers completed a brief mood scale (Parrott et al.,
1996) prepatch, prescan, and postscan; nonsmokers completed theincreases in brain activity and task performance would
mood scale pre- and postscan only. The mood scale contained ninebe observed in nonsmokers.
bipolar questions: tense/relaxed, nervous/calm, energetic/tired,
alert/drowsy, content/irritated, satisfied/dissatisfied, focused/dis-
Experimental Procedures tracted, happy/depressed, hungry/satiated. Responses were
scored on five point bipolar scales: strongly – slightly – neither –
Subjects slightly – strongly (0–4). Mood data in smokers were analyzed with
Subjects were recruited through television and newspaper adver- 2  3 repeated-measures ANOVA, with drug (placebo/nicotine) and
tisements and were paid for their participation. Young, healthy, right- time (prepatch, 2 hr postpatch, and postscan) as the repeated mea-
handed (Oldfield, 1971) smokers (n  15) and nonsmokers (n  14) sures. Smokers were compared to nonsmokers using a 2 2 ANOVA
participated in this study. Nonsmokers (seven females, mean age with time (pre-/postscan) as the repeated-measure and smoking
22.4 years, SD  4.1 [range 18 to 34 years], mean education  14.5 status (smoker/nonsmoker) as the between-subjects factor.
years, SD  2.35) were matched to smokers (seven females, mean Smokers were scanned on two occasions: while wearing either a
age  22.2 years, SD  4.4 [range 18 to 35 years], mean education 21 mg nicotine patch (Nicoderm CQ, SmithKline Beecham) or a
of 13.1 years, SD  1.51) for age (2 years) and education (3 placebo patch (a square, two layers-thick boxing tape, which was
years, except for two subjects [4–5 years]). Individuals smoked at the same size, thickness, and stickiness as the nicotine patch).
least 15 cigarettes per day (mean  21.8, SD  4.5) for an average Patch application followed a counterbalanced, single blind design
of 6.3 years (SD  2.8 years) and scored an average 4.5 (SD  and was applied under a large bandage to the upper back area by
1.3) out of a maximum of 10 on the Fagerstrom index of smoking the experimenter 2 hr prior to the scan. The 28 min RVIP task was
dependency (Heatherton et al., 1991). They had no previous history performed in the scanner 2.30 hr after patch application: about
of any neurological or psychiatric disorder and no other drug depen- midway through its reported effective range (Mancuso et al., 1999).
dence, although four subjects (three smokers) reported occasional
use of THC. After complete description of the study, subjects gave fMRI Parameters
written informed consent to the Medical College of Wisconsin Insti- Scanning was performed on a 3T Bruker Medspec scanner equipped
with a 30.5 cm i.d. three-axis local gradient coil and an endcappedtutional Review Board approved protocol. Subjects smoked their
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